IS6477A - Afleiður piperazíns og piperadíns - Google Patents

Afleiður piperazíns og piperadíns

Info

Publication number: IS6477A
Authority: IS; Iceland
Prior art keywords: piperadine; piperazine; derivatives
Prior art date: 2000-02-11

Application number

IS6477A

Other languages

English (en)

Inventor

Tomlinson Ronald

Lauffer David

Mullican Michael

Marks Andrew

Original Assignee

Vertex Pharmaceuticals Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-11

Filing date

2002-07-19

Publication date

2002-07-19

2002-07-19 Application filed by Vertex Pharmaceuticals Inc. filed Critical Vertex Pharmaceuticals Inc.

2002-07-19 Publication of IS6477A publication Critical patent/IS6477A/is

Links

NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 1
150000004885 piperazines Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Thiazole And Isothizaole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrrole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Indole Compounds (AREA)

IS6477A 2000-02-11 2002-07-19 Afleiður piperazíns og piperadíns IS6477A (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US18194400P	2000-02-11	2000-02-11
US24733000P	2000-11-10	2000-11-10
PCT/US2001/004210 WO2001058891A2 (en)	2000-02-11	2001-02-09	Piperazine and piperidine derivatives for treatment or prevention of neuronal damage

Publications (1)

Publication Number	Publication Date
IS6477A true IS6477A (is)	2002-07-19

Family

ID=26877657

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6477A IS6477A (is)	2000-02-11	2002-07-19	Afleiður piperazíns og piperadíns

Country Status (23)

Country	Link
EP (1)	EP1257544B1 (is)
JP (1)	JP2003522767A (is)
KR (1)	KR20020073586A (is)
CN (1)	CN1210274C (is)
AP (1)	AP2002002596A0 (is)
AU (1)	AU4146401A (is)
BR (1)	BR0108175A (is)
CA (1)	CA2398822A1 (is)
CO (1)	CO5261503A1 (is)
CZ (1)	CZ20022720A3 (is)
EA (1)	EA200200847A1 (is)
EE (1)	EE200200442A (is)
HR (1)	HRP20020737A2 (is)
HU (1)	HUP0301391A3 (is)
IL (1)	IL150849A0 (is)
IS (1)	IS6477A (is)
MX (1)	MXPA02007790A (is)
NO (1)	NO20023787L (is)
NZ (1)	NZ520638A (is)
PE (1)	PE20011081A1 (is)
PL (1)	PL357177A1 (is)
SK (1)	SK11452002A3 (is)
WO (1)	WO2001058891A2 (is)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6376514B1 (en)	2000-10-17	2002-04-23	The Procter & Gamble Co.	Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US6693099B2 (en)	2000-10-17	2004-02-17	The Procter & Gamble Company	Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6809093B2 (en)	2000-10-17	2004-10-26	H. Lee Moffitt Cancer & Research Institute, Inc.	2-substituted heterocyclic compounds
JP4104983B2 (ja) *	2001-02-28	2008-06-18	メルクエンドカムパニーインコーポレーテッド	メラノコルチン−４受容体作動薬としてのアシル化ピペリジン誘導体
AU2002250343B2 (en)	2001-02-28	2006-05-25	Merck Sharp & Dohme Corp.	Acylated piperidine derivatives as melanocortin-4 receptor agonists
DE60215132T2 (de)	2001-02-28	2007-08-23	Merck & Co., Inc.	Acylierte piperidin-derivate als melanocortin-4-rezeptor-agonisten
ATE411021T1 (de)	2001-07-18	2008-10-15	Merck & Co Inc	Überbrückte piperidinderivate als melanocortin- rezeptor-agonisten
TWI329108B (en) *	2001-09-06	2010-08-21	Schering Corp	17-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
JP2005511560A (ja) *	2001-11-01	2005-04-28	バーテックスファーマシューティカルズインコーポレイテッド	コレステロール生合成経路の変調
AU2003268493A1 (en)	2002-09-11	2004-04-30	Merck & Co., Inc.	Piperazine urea derivatives as melanocortin-4 receptor agonists
PL376149A1 (en) *	2002-10-03	2005-12-27	Vertex Pharmaceuticals Incorporated	Piperazine and piperidine derivatives for treatment of neurological diseases
WO2004078717A1 (en) *	2003-03-03	2004-09-16	Merck & Co., Inc.	Acylated piperazine derivatives as melanocortin-4 receptor agonists
CN101880277A (zh)	2003-04-24	2010-11-10	因塞特公司	作为金属蛋白酶抑制剂的氮杂螺烷衍生物
EP1524265A1 (en) *	2003-10-15	2005-04-20	Newron Pharmaceuticals S.p.A.	Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors
CN1988906A (zh)	2004-07-19	2007-06-27	默克公司	用作黑皮质素－4受体激动剂的酰基化哌啶衍生物
GB0508319D0 (en)	2005-04-25	2005-06-01	Novartis Ag	Organic compounds
EP1902046B1 (en) *	2005-06-20	2009-12-02	Schering Corporation	Piperidine derivatives useful as histamine h3 antagonists
ATE450525T1 (de)	2005-06-20	2009-12-15	Schering Corp	Kohlenstoffgebundene substituierte piperidine und derivate daraus als histamin-h3-antagonisten
GB0514018D0 (en) *	2005-07-07	2005-08-17	Ionix Pharmaceuticals Ltd	Chemical compounds
US7935342B2 (en)	2006-02-02	2011-05-03	Rinat Neuroscience Corp.	Methods for treating obesity by administering a trkB antagonist
SI2076508T1 (sl)	2006-10-18	2011-04-29	Pfizer Prod Inc	Spojine biaril eter sečnine
EP2358200A4 (en)	2008-11-17	2012-05-16	Merck Sharp & Dohme	SUBSTITUTED BICYCLIC AMINES FOR THE TREATMENT OF DIABETES
CA2768577A1 (en)	2009-07-23	2011-01-27	Schering Corporation	Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
WO2011011506A1 (en)	2009-07-23	2011-01-27	Schering Corporation	Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
WO2011137024A1 (en)	2010-04-26	2011-11-03	Merck Sharp & Dohme Corp.	Novel spiropiperidine prolylcarboxypeptidase inhibitors
EP2568812B1 (en)	2010-05-11	2016-10-26	Merck Sharp & Dohme Corp.	Novel prolylcarboxypeptidase inhibitors
EP2579873A4 (en)	2010-06-11	2013-11-27	Merck Sharp & Dohme	NOVEL PROLYLCARBOXYPEPTIDASE HEMMER
US8729263B2 (en)	2012-08-13	2014-05-20	Novartis Ag	1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
EA030631B1 (ru) *	2013-07-31	2018-09-28	Новартис Аг	1,4-дизамещенные аналоги пиридазинхинолина и способы лечения состояний, связанных с smn-дефицитом
JP6985179B2 (ja) *	2018-02-27	2021-12-22	田辺三菱製薬株式会社	プロリンアミド化合物の製造方法
TW202108559A (zh)	2019-05-31	2021-03-01	美商醫肯納腫瘤學公司	Tead抑制劑及其用途
BR112021024108A2 (pt)	2019-05-31	2022-03-22	Ikena Oncology Inc	Inibidores de tead e usos dos mesmos

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE791501A (fr) *	1971-11-19	1973-05-17	Albert Ag Chem Werke	Diamines cycliques n,n'-disubstituees et leur procede de preparation
US3862937A (en) *	1972-02-23	1975-01-28	Univ Mississippi	6-Phenethyl-3-piperidinecarboxamides
FR2597100A1 (fr) *	1986-01-21	1987-10-16	Nippon Shinyaku Co Ltd	Derives du pyroglutamide
US4745123A (en) *	1986-02-18	1988-05-17	Warner-Lambert Company	Substituted tetrahydro-3-pyridine-carboxylic acid, ester, and amide cholinergic agents
NZ228329A (en) *	1988-03-18	1991-12-23	Mitsui Toatsu Chemicals	Catechol derivatives and pharmaceutical compositions thereof
US5232923A (en) *	1988-03-18	1993-08-03	Mitsui Toatsu Chemicals, Incorporated	Catechol derivatives and pharmaceutical preparations containing same
US5290793A (en) *	1989-09-12	1994-03-01	Mitsui Toatsu Chemicals, Incorporated	Dihydrocaffeic acid derivatives and pharmaceutical preparation containing same
FR2705095B1 (fr)	1993-05-12	1995-06-23	Adir	Nouveaux indoles substitués, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5614547A (en)	1995-06-07	1997-03-25	Guilford Pharmaceuticals Inc.	Small molecule inhibitors of rotamase enzyme
US5811434A (en) *	1996-11-13	1998-09-22	Vertex Pharmacueticals Incorporated	Methods and compositions for stimulating neurite growth
AR010744A1 (es) *	1996-12-09	2000-07-12	Guildford Pharmaceuticals Inc	Inhibidores polipropilos de ciclofilina
JPH11106375A (ja) *	1997-08-18	1999-04-20	Pfizer Pharmaceut Inc	ブラジキニンアンタゴニストとしての光学的に活性な１，４−ジヒドロピリジン化合物

2001
- 2001-02-09 EA EA200200847A patent/EA200200847A1/ru unknown
- 2001-02-09 PL PL01357177A patent/PL357177A1/xx not_active Application Discontinuation
- 2001-02-09 CZ CZ20022720A patent/CZ20022720A3/cs unknown
- 2001-02-09 PE PE2001000144A patent/PE20011081A1/es not_active Application Discontinuation
- 2001-02-09 HU HU0301391A patent/HUP0301391A3/hu unknown
- 2001-02-09 NZ NZ520638A patent/NZ520638A/en unknown
- 2001-02-09 HR HR20020737A patent/HRP20020737A2/hr not_active Application Discontinuation
- 2001-02-09 IL IL15084901A patent/IL150849A0/xx unknown
- 2001-02-09 CO CO01009891A patent/CO5261503A1/es unknown
- 2001-02-09 SK SK1145-2002A patent/SK11452002A3/sk not_active Application Discontinuation
- 2001-02-09 MX MXPA02007790A patent/MXPA02007790A/es unknown
- 2001-02-09 EE EEP200200442A patent/EE200200442A/xx unknown
- 2001-02-09 BR BR0108175-6A patent/BR0108175A/pt not_active IP Right Cessation
- 2001-02-09 CA CA002398822A patent/CA2398822A1/en not_active Abandoned
- 2001-02-09 KR KR1020027010367A patent/KR20020073586A/ko not_active Ceased
- 2001-02-09 EP EP01912714A patent/EP1257544B1/en not_active Expired - Lifetime
- 2001-02-09 JP JP2001558441A patent/JP2003522767A/ja active Pending
- 2001-02-09 CN CNB018048021A patent/CN1210274C/zh not_active Expired - Fee Related
- 2001-02-09 AU AU41464/01A patent/AU4146401A/en not_active Abandoned
- 2001-02-09 AP APAP/P/2002/002596A patent/AP2002002596A0/en unknown
- 2001-02-09 WO PCT/US2001/004210 patent/WO2001058891A2/en not_active Ceased
2002
- 2002-07-19 IS IS6477A patent/IS6477A/is unknown
- 2002-08-09 NO NO20023787A patent/NO20023787L/no unknown

Also Published As

Publication number	Publication date
NO20023787L (no)	2002-10-11
HUP0301391A2 (hu)	2003-08-28
EP1257544A2 (en)	2002-11-20
PL357177A1 (en)	2004-07-26
HRP20020737A2 (en)	2005-10-31
JP2003522767A (ja)	2003-07-29
MXPA02007790A (es)	2002-10-17
AP2002002596A0 (en)	2002-09-30
SK11452002A3 (sk)	2003-03-04
AU4146401A (en)	2001-08-20
EA200200847A1 (ru)	2003-02-27
EE200200442A (et)	2003-12-15
BR0108175A (pt)	2003-01-28
EP1257544B1 (en)	2012-07-25
CN1210274C (zh)	2005-07-13
CZ20022720A3 (cs)	2002-11-13
PE20011081A1 (es)	2001-10-22
HUP0301391A3 (en)	2010-03-29
NZ520638A (en)	2004-05-28
CO5261503A1 (es)	2003-03-31
WO2001058891A3 (en)	2002-04-25
KR20020073586A (ko)	2002-09-27
NO20023787D0 (no)	2002-08-09
CN1404477A (zh)	2003-03-19
IL150849A0 (en)	2003-02-12
WO2001058891A2 (en)	2001-08-16
CA2398822A1 (en)	2001-08-16

Publication	Publication Date	Title
IS6477A (is)	2002-07-19	Afleiður piperazíns og piperadíns
DK1233964T3 (da)	2005-09-19	Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
IS6934A (is)	2003-08-29	Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
NO20032668D0 (no)	2003-06-12	Gyraseinhibitorer og anvendelser derav
DK1251848T3 (da)	2004-10-18	Gyraseinhibitorer og anvendelse deraf
ATE397595T1 (de)	2008-06-15	Piperazin-derivate
DZ3306A1 (fr)	2001-10-04	Derives de piperazine
ATE253576T1 (de)	2003-11-15	8-chinolinxanthin and 8-isochinolinxanthin derivate als pde 5 inhibitoren
AR028567A1 (es)	2003-05-14	Nuevos derivados de fenil-propargileter
DK1198453T3 (da)	2003-07-21	N-(indolcarbonyl-)piperazinderivater
AR028596A1 (es)	2003-05-14	Nuevos derivados de fenilglicina
PT1326853E (pt)	2005-11-30	Novos tiadiazoles e oxadiazoles e sua utilizacao como inibidores da fosfodiesterase-7
NO20023342D0 (no)	2002-07-11	Fremgangsmåte for fjernelse av NOX og N2O
AR028281A1 (es)	2003-04-30	Derivados de 2-(arilalquilamino) pirimidona y derivados de 2-(heteroaroarilalquilamino) pirimidona
NO20033854D0 (no)	2003-09-01	N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
ATE255578T1 (de)	2003-12-15	Piperazin- und piperidinverbindungen
NO20011026D0 (no)	2001-02-28	Matvare og fremgangsmÕte for fremstilling derav
NO20025968D0 (no)	2002-12-12	Pyridin-2-yl-aminoalkylkarbonylglycyl-<beta>-alanin og derivater derav
NO20035332D0 (no)	2003-11-28	Nye heterocykliske derivater og medisinsk anvendelse derav
IS6752A (is)	2003-03-21	Afleiður tryptamíns og hliðstæð efnasambönd ásamtlyfjaforskriftum þeirra
NO20030822L (no)	2003-03-31	Nye forbindelser og fremgangsmåter
DE60117096D1 (de)	2006-04-20	Dihydroindol- und tetrahydrochinolinderivate
DE60113689D1 (de)	2006-02-09	2-aminothiazolinderivate und ihre verwendung als no-synthase inhibitoren
ATE299873T1 (de)	2005-08-15	Substituierte c-furan-2-yl-methylamin- und c- thiophen-2-yl-methylamin-derivate
DE60106740D1 (de)	2004-12-02	Hydrazid und alkoxyamid angiogeneseinhibitoren